StemMACS™ Lin28 mRNA encodes the human RNA-binding protein Lin28 and is designed for transient transfection.
Related products for StemMACS™ Lin28 mRNA, human
Lin28 expression after mRNA transfection: Human BJ fibroblasts were transfected once with 150 ng StemMACS™ Lin28 mRNA. 24 hours after transfection, Lin28 expression (magenta) and cytoplamic localization (DAPI counterstain) were analyzed by immunofluorescence microscopy.
- Modulation of pluripotency
- Reprogramming
StemMACS™ Lin28 mRNA encodes the human RNA-binding protein Lin28 and is designed for transient transfection.
The RNA binding protein Lin28 is a conserved regulator of cell fate. In vertebrates, Lin28 promotes pluripotency and controls differentiation in diverse tissues. Lin28 can directly inhibit let-7 microRNA processing. It is highly expressed in human embryonic stem cells and has been used to enhance the generation of induced pluripotent stem cells.
For satisfactory transfection results, use a transfection protocol optimized for your specific cell type. StemMACS™ eGFP mRNA or StemMACS™ Nuclear eGFP mRNA allow easy evaluation of transfection efficiency and are recommended as positive controls.
StemMACS™ mRNAs are highly pure, in vitro-transcribed mRNAs that have been carefully optimized to ensure high level expression after transfection. Polyadenylation and enzymatic cap mimic a fully processed mature mRNA and ensure efficient translation. Incorporation of the modified nucleotides pseudouridine and 5-methylcytidine reduces the innate antiviral response to single-stranded mRNA. Robust expression of the encoded factor after transfection has been verified by immunofluorescence or flow cytometry.
StemMACS™ mRNAs are lyophilized from a 0.2 µM filtered solution for extended shelf-life.
You have previously chosen International as your location.
What do you want to do?